BREAST DUCTAL CARCINOMA IN SITU
Clinical trials for BREAST DUCTAL CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST DUCTAL CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST DUCTAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Landmark breast cancer study finds chemo not needed for many women with positive nodes
Disease control OngoingThis large phase 3 trial studied over 5,000 women with hormone receptor-positive, HER2-negative breast cancer that had spread to 1-3 lymph nodes. Participants received standard hormone therapy (tamoxifen or an aromatase inhibitor) either alone or with chemotherapy. The goal was t…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
Fasting plus diabetes drug may shrink breast tumors before surgery
Disease control OngoingThis study looks at whether combining a nightly fast (time-restricted eating) with the diabetes drug metformin can reduce breast cancer cell growth in women with early-stage invasive breast cancer or ductal carcinoma in situ (DCIS). About 120 participants will follow the fasting …
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New gel could fight breast cancer before surgery
Disease control OngoingThis early-stage trial tests a gel form of the drug endoxifen on women scheduled for breast surgery. The goal is to find the safest dose and see if it can treat or lower the risk of breast cancer. About 32 women with various stages of breast cancer or high risk will apply the gel…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Which cream soothes radiation burns best? aquaphor vs miaderm showdown
Symptom relief OngoingThis study compares two over-the-counter creams, Aquaphor and Miaderm, to see which one better treats the painful skin rash caused by radiation therapy in breast cancer patients. About 208 women receiving radiation after breast cancer surgery will use one of the creams and report…
Matched conditions: BREAST DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated May 17, 2026 05:47 UTC